Evogene Ltd. (EVGN)
NASDAQ: EVGN · IEX Real-Time Price · USD
0.620
+0.026 (4.43%)
Jul 22, 2024, 10:11 AM EDT - Market open
Evogene Employees
Evogene had 142 employees as of December 31, 2023. The number of employees increased by 5 or 3.65% compared to the previous year.
Employees
142
Change (1Y)
5
Growth (1Y)
3.65%
Revenue / Employee
$64,711
Profits / Employee
-$151,204
Market Cap
31.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
Rapid Micro Biosystems | 193 |
Pluri | 134 |
Spectral AI | 78 |
NKGen Biotech | 63 |
Equillium | 44 |
MiNK Therapeutics | 31 |
Daré Bioscience | 26 |
EVGN News
- 5 days ago - ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants - PRNewsWire
- 20 days ago - Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat - PRNewsWire
- 27 days ago - Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country - PRNewsWire
- 2 months ago - Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma - PRNewsWire
- 2 months ago - Evogene Reports First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds - PRNewsWire
- 2 months ago - Evogene Schedules First Quarter 2024 Financial Results Release - PRNewsWire
- 3 months ago - Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - PRNewsWire